Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
2.
Injury ; 41(7): 687-92, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19880111

RESUMO

Several observational and experimental studies have investigated the potential anabolic effects of statins on undisturbed bone but only a few recent studies have examined the effect of statins on skeletal repair. The goal of the study is to investigate any potential early anabolic effect of the systemic administration of simvastatin in low doses (based on earlier safety and efficacy studies on undisturbed bone) on fracture healing. Fifty-four skeletally mature male New Zealand White rabbits were used for the study. The rabbits were assigned to one of three experimental groups: a control group, and two groups that were orally administrated a diet with 10 and 30 mg/kg/day of simvastatin, respectively. A complete biochemical blood count was performed to exclude drug-induced complications. Half of the animals of each group were sacrificed at 15 days and the other half at 30 days after surgery at which time intervals healing quality was assessed. The bones were subjected to biomechanical testing, histomorphometric analysis and peripheral quantitative computed tomography. In animals received simvastatin of 30 mg/kg/day a significant reduction of BMD, stiffness, and energy absorbed to failure were observed. At 15 days, the amount of cartilaginous callus formation was reduced, and the void space was significantly increased, in the animals of both groups that received simvastatin when compared to the control group (p<.05). Our results suggest that simvastatin doses of 30 mg/kg/day may have a negative anabolic effect on callus formation in rabbits, whereas doses of 10 mg/kg/day seem not to produce a significant positive or a negative effect, especially at the early stages of fracture remodeling.


Assuntos
Densidade Óssea/efeitos dos fármacos , Consolidação da Fratura/efeitos dos fármacos , Sinvastatina/administração & dosagem , Fraturas da Ulna/tratamento farmacológico , Animais , Fenômenos Biomecânicos , Densidade Óssea/fisiologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Consolidação da Fratura/fisiologia , Masculino , Coelhos , Sinvastatina/farmacologia , Fraturas da Ulna/fisiopatologia
3.
Am J Reprod Immunol ; 59(4): 306-15, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18294356

RESUMO

PROBLEM: Increased peripheral blood natural killer (NK) cells are associated to immune-mediated abortion, but their diagnostic value when measured at the time of miscarriage is unknown. METHOD OF STUDY: In women with therapeutic (A = 79) or elective (C = 34) pregnancy termination, the NK-cell percentage was measured before and 5 days after curettage. Additionally, immune-mediated lesions (scored 0-3) and CD56(+) and CD16(+) decidual NKs (scored 1-3) were detected on the abortion material. RESULTS: Aborters differed from controls in histological scores (P = 0.000) and in NK percentage (>12%) only in the measurement 5 days after the operation (P = 0.038). In comparison to histological lesions, NK measurement was found to have sensitivity 70%, specificity 73.68%, positive prognostic value 89.39% and negative prognostic value 43.75%. CONCLUSION: An Increased NK-cell percentage 5 days after the pregnancy termination could be a marker of immune aetiology of miscarriage, as the probability of an aborter with NK >12% to have an immune-mediated abortion is almost 90%.


Assuntos
Aborto Retido/sangue , Aborto Retido/imunologia , Células Matadoras Naturais/citologia , Células Matadoras Naturais/imunologia , Aborto Retido/diagnóstico , Aborto Retido/patologia , Adulto , Anticorpos Monoclonais/imunologia , Antígeno CD56/análise , Vilosidades Coriônicas/imunologia , Vilosidades Coriônicas/patologia , Feminino , Humanos , Imuno-Histoquímica , Queratinas/análise , Queratinas/imunologia , Contagem de Linfócitos , Valor Preditivo dos Testes , Receptores de IgG/análise , Fatores de Tempo
4.
Int J Hematol ; 86(4): 333-6, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18055340

RESUMO

A 47-year-old woman presented with severe hemolytic uremic syndrome (HUS) followed by heart failure. An echocardiogram showed an ejection fraction of 20%, and a cardiac catheterization followed by a myocardial histologic evaluation demonstrated dilated cardiomyopathy. Plasma exchange and hemodialysis were performed regularly. The later outcomes of renal function and cardiomyopathy were favorable. A review of the literature confirmed the rare and severe nature of cardiac lesions occurring in the course of HUS. This case indicates the importance of cardiac monitoring in HUS and the need for prolonged support.


Assuntos
Cardiomiopatia Dilatada/etiologia , Cardiomiopatia Dilatada/patologia , Síndrome Hemolítico-Urêmica/complicações , Síndrome Hemolítico-Urêmica/patologia , Feminino , Humanos , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA